Caricamento...
Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing
Despite early successes using recombinant adeno-associated virus (rAAV) vectors in clinical gene therapy trials, limitations remain making additional advancements a necessity. Some of the challenges include variable levels of pre-existing neutralizing antibodies and poor transduction in specific tar...
Salvato in:
| Pubblicato in: | Hum Gene Ther |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Mary Ann Liebert, Inc., publishers
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7232707/ https://ncbi.nlm.nih.gov/pubmed/32024384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2019.339 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|